- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
SMS Lifesciences has announced a board meeting on May 16, 2025, to consider the financial results for the quarter and half-year.
The company recently completed a US FDA inspection at its API manufacturing site, which resulted in one procedural observation. This issue does not affect data integrity, product quality, or operations, and carries no financial impact. SMS Lifesciences is submitting a formal response to obtain final approval (EIR).
Investors should view this as a routine regulatory step with low risk, with the company taking prompt action to maintain compliance.